According to the current analysis of Reports and Data, the Global Auditory Brainstem Implant Market was valued at USD 59.77 Million in 2019 and is expected to reach USD 79.66 Million by the year 2027, at a CAGR of 3.6%. An auditory brainstem implant (ABI) is operated on people suffering from profound sensorineural hearing loss. The auditory brainstem implants directly aid in the functioning of the hearing pathway of the brainstem without any interaction with the hearing nerve or inner ear, which involves complex neurosurgery to the brainstem. The major use of this procedure is for the adults diagnosed with neurofibromatosis type 2, a rare genetic disorder that causes the development of tumors on the nerve.
However, it is being operated now on children as well as adults with other inner ear and nerve abnormalities. One of the first hearing aid machines for brainstem implants were by Cochlear Ltd.’s, a leading company in the electronic hearing machines industry, Nucleus 24 ABI for teenagers and adults, which got FDA approved in the year 2000. In recent years few other machines have gained popularity due to their MRI compatible machines. The machine comprises a receiver/stimulator, a pocket-sized speech processor worn on the body, and the microphone/headset. Other applications of this procedure are associated with people who do not have an operational hearing nerve in either ear or with deaf people due to their abnormally-shaped cochlea.
Factors responsible for hearing loss include complications present by birth, infectious diseases, genetic origins, chronic infections of the ear, contact to excessive noise, through consumption of particular drugs, and aging.
Request free sample Copy of this research report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/2173
According to the World Health Organization, approximately 466 million people across the globe have disabling hearing loss, out of which 34 million are children. It is projected that by 2050 around 900 million individuals will have disabling hearing loss. These dynamics are likely to affect the ABI market in the future. Other factors such as the rising geriatric population, increasing incidence of hearing loss by birth, and rising noise pollution issues around the globe are anticipated to drive the market. However, the brainstem implants are associated with few risks during and after the implantations, which will impede the growth of this industry.
ABI is generally adopted if the patient cannot be benefited from the commonly operated hearing aid or cochlear implants. The cochlear implants cannot be operated in conditions when the hearing nerve is tiny in size or is completely absent, and in some rare cases, the inner ear is severely abnormal. The auditory brain implants market has attained significant advances in recent years. The innovations in neuroprosthetic technology are anticipated to support the cochlear implants’ adoption that includes auditory brainstem implants. The auditory brainstem implantation technique is more complicated than the cochlear implantation, but the device provides significant advantages to the patients with some unmet needs. It also benefits hearing loss patients in lip reading along with sound recognition.
Based on the regional perspective, North America holds the largest share in surgeries associated with the brainstem. The Asia Pacific is a growing market and is expected to grow at the highest rate in the future due to its huge consumer base, mainly in developing areas such as India and China. The increasing healthcare expenditure is likely to propel the market.
Furthermore, increased government initiatives, availability of research funds from private as well as public bodies, improvement in the reimbursement scenario for hearing associated implantation, and rising awareness about benefits of auditory brainstem implants are among the key factors propelling the growth of Auditory Brainstem Implant market.
Further key findings from the report suggest
- According to the CDC (Center for Disease Control and Prevention), over 30% of the total hearing loss complications after birth are caused by infections during pregnancy, environmental causes, and certain complications after birth. Moreover, according to the data, nearly 50-60% of the cases of hearing loss in children are due to the genetic defects which lead to further complications.
- Current cochlear implants are unable to regain hearing in patients with an inner ear injury. It is required to have a direct electrical stimulation of the auditory brainstem, which can be achieved using an ABI. The success of neuroprosthetic ABIs has been limited, with patients often only recovering sound perception rather than full hearing.
- The clinical ABI machines are stiff and creates hindrance in hearing due to the brainstem’s curved shape. A research Institute of Switzerland called EPFL with clinicians from Harvard Medical School, and Massachusetts Eye and Ear developed a new implant device of the soft electronic interface made from a pliable platinum array. This device is elastic and comfortable to be fitted around the curvature of the brainstem.
- North America remains the key revenue-generating geographical segment in the Auditory Brainstem Implant market. The geographical segment accounted for more than USD 20.8 million by 2019. Availability of research funds from the public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements for implantation procedures, rising focus on precision devices, and rising awareness about the effectiveness of implantation surgeries, are among the key factors driving the market growth for Auditory Brainstem Implant in this region.
- The global Auditory Brainstem Implant market is highly fragmented with major players like Cochlear Limited (Australia), Med-EL (Austria), Oticon Medical (Denmark), Nurotron’s Biotechnology Co. Ltd. (China), and Sonova Holding AG (Switzerland), collectively constituting a competitive market.
Order Your Copy Now (Customized report delivered as per your specific requirement)@ https://www.reportsanddata.com/checkout-form/2173
For the purpose of this report, Reports and Data has segmented the Auditory Brainstem Implant market on the basis of Medical Condition, Components Used, End-Users, and Region:
Medical Condition Outlook (Revenue in Million USD; 2017–2027)
- Major Cochlear Malformation
- Complete Cochlear Ossification
- Fracture of the Petrous Pyramid
- Axonal Neuropathy
- Auditory Nerve Tumours
- Complete Obliteration of both Auditory Nerves
Components Outlook (Revenue in Million USD; 2017–2027)
- Decoding Chip
End-User Outlook (Revenue in Million USD; 2017–2027)
Regional Outlook (Revenue in Million USD; 2017–2027)
- North America
- Rest of the Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Latin America
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/auditory-brainstem-implant-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370